Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cervical Cancer

Free Subscription Articles published in Acta Obstet Gynecol Scand Retrieve available abstracts of 39 articles: HTML format

Single Articles

July 2024
1. LINDQUIST S, Kjaer SK, Frederiksen K, Ornskov D, et al
   Clinical performance of human papillomavirus based cervical cancer screening algorithm: The result of a large Danish implementation study.
   Acta Obstet Gynecol Scand. 2024 Jul 16. doi: 10.1111/aogs.14915.
   PubMed     Abstract available
   
   
   June 2024
2. CASSANI C, Dominoni M, Pasquali MF, Gardella B, et al
   The role of multiple high-risk human papillomavirus infection on the persistence recurrence of high-grade cervical lesions after standard treatment: A systematic review and a meta-analysis.
   Acta Obstet Gynecol Scand. 2024;103:1028-1035.
   PubMed     Abstract available
   
   
   February 2024
3. LINDROTH Y, Pedersen L, Alssamaray J, Berglund T, et al
   Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
   Acta Obstet Gynecol Scand. 2024;103:378-386.
   PubMed     Abstract available
   
   
   January 2024
4. BOHLIN KS, Brannstrom M, Dahm-Kahler P
   Gynecological cancer during pregnancy-From a gyne-oncological perspective.
   Acta Obstet Gynecol Scand. 2024 Jan 6. doi: 10.1111/aogs.14763.
   PubMed     Abstract available
   
   
   October 2023
5. HELLSTEN C, Holmberg A, Astrom J, Forslund O, et al
   Cervical cancer in Region Skane, Sweden 2017-2020 after the implementation of primary HPV screening: A quality assurance audit.
   Acta Obstet Gynecol Scand. 2023 Oct 10. doi: 10.1111/aogs.14691.
   PubMed     Abstract available
   
   
   September 2023
6. DAMGAARD RK, Jenkins D, Stoler MH, van de Sandt MM, et al
   High prevalence of HPV16 and high-grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
   Acta Obstet Gynecol Scand. 2023;102:1227-1235.
   PubMed     Abstract available
   
   
   August 2023
7. SOARES LC, de Souza RJ, Oliveira MAP
   Reviewing FIGO 2018 cervical cancer staging.
   Acta Obstet Gynecol Scand. 2023 Aug 17. doi: 10.1111/aogs.14667.
   PubMed    
   
   
   
8. HARRIS CA, Mandelbaum RS, Rau AR, Song BB, et al
   Contraception and sterilization selection at delivery among pregnant patients with malignancy.
   Acta Obstet Gynecol Scand. 2023 Aug 14. doi: 10.1111/aogs.14654.
   PubMed     Abstract available
   
   
   
9. XUE P, Xu HM, Tang HP, Wu WQ, et al
   Assessing artificial intelligence enabled liquid-based cytology for triaging HPV-positive women: a population-based cross-sectional study.
   Acta Obstet Gynecol Scand. 2023;102:1026-1033.
   PubMed     Abstract available
   
   
   June 2023
10. DUAN H, Li H, Kang S, Zhao H, et al
    Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
    Acta Obstet Gynecol Scand. 2023 Jun 20. doi: 10.1111/aogs.14612.
    PubMed     Abstract available
    
    
    
11. SKORSTENGAARD M, Viborg PH, Telen Andersen AB, Andersen B, et al
    A cervical screening initiative for elderly women in Denmark.
    Acta Obstet Gynecol Scand. 2023;102:791-800.
    PubMed     Abstract available
    
    
    May 2023
12. ALFONZO E, Zhang C, Daneshpip F, Strander B, et al
    Accuracy of colposcopy in the Swedish screening program.
    Acta Obstet Gynecol Scand. 2023;102:549-555.
    PubMed     Abstract available
    
    
    March 2023
13. FOTHERINGHAM P, Safi N, Li Z, Anazodo A, et al
    Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study.
    Acta Obstet Gynecol Scand. 2023 Mar 13. doi: 10.1111/aogs.14530.
    PubMed     Abstract available
    
    
    January 2023
14. DAHL AA, Bentzen AG, Fossa SD, Hess SL, et al
    A study of modifiable factors associated with health-related quality of life in long-term cervical cancer survivors.
    Acta Obstet Gynecol Scand. 2023 Jan 23. doi: 10.1111/aogs.14490.
    PubMed     Abstract available
    
    
    
15. JANSAKER F, Li X, Sundqvist A, Sundquist K, et al
    Cervical neoplasia in relation to socioeconomic and demographic factors - a nationwide cohort study (2002-2018).
    Acta Obstet Gynecol Scand. 2023;102:114-121.
    PubMed     Abstract available
    
    
    December 2022
16. FELDSTEIN O, Gali-Zamir H, Schejter E, Feinberg T, et al
    High-risk HPV testing vs liquid-based cytology for cervical cancer screening among 25- to 30-year-old women: A historical cohort study.
    Acta Obstet Gynecol Scand. 2022 Dec 7. doi: 10.1111/aogs.14482.
    PubMed     Abstract available
    
    
    November 2022
17. EBISCH RMF, Rijstenberg LL, Soltani GG, van der Horst J, et al
    Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population.
    Acta Obstet Gynecol Scand. 2022;101:1328-1336.
    PubMed     Abstract available
    
    
    June 2022
18. PENG H, He X, Wang Q
    Immune checkpoint blockades in gynecological cancers: A review of clinical trials.
    Acta Obstet Gynecol Scand. 2022 Jun 25. doi: 10.1111/aogs.14412.
    PubMed     Abstract available
    
    
    
19. BAASLAND I, Vie GA, Romundstad PR, Lonnberg S, et al
    Cervical cancer mortality in Norway according to screening attendance and age.
    Acta Obstet Gynecol Scand. 2022 Jun 11. doi: 10.1111/aogs.14402.
    PubMed     Abstract available
    
    
    
20. HAMMER A, Blaakaer J, de Koning MNC, Steiniche T, et al
    Evidence of latent HPV infection in older Danish women with a previous history of cervical dysplasia.
    Acta Obstet Gynecol Scand. 2022;101:608-615.
    PubMed     Abstract available
    
    
    
21. ERIKSEN DO, Jensen PT, Schroll JB, Hammer A, et al
    Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta-analysis.
    Acta Obstet Gynecol Scand. 2022;101:597-607.
    PubMed     Abstract available
    
    
    
22. HANSEN J, Kirkegaard P, Folmann B, Bungum HF, et al
    "I feel reassured, but there is no guarantee." How do women with a future childbearing desire respond to active surveillance of cervical intraepithelial neoplasia grade 2? A qualitative study.
    Acta Obstet Gynecol Scand. 2022;101:616-623.
    PubMed     Abstract available
    
    
    May 2022
23. BONEFELD RE, Poulsgaard Frandsen A, Christensen J, Larsen T, et al
    A walk-in clinic as an alternative approach to reaching non-attenders of the cervical cancer screening program in the North Denmark region-a pilot study.
    Acta Obstet Gynecol Scand. 2022 May 11. doi: 10.1111/aogs.14377.
    PubMed     Abstract available
    
    
    March 2022
24. BORGFELDT C, Leksell A, Forslund O
    Co-testing in cervical screening among 40- to 42-year-old women is unreasonable.
    Acta Obstet Gynecol Scand. 2022;101:374-378.
    PubMed     Abstract available
    
    
    February 2022
25. OLTHOF EP, Mom CH, Snijders MLH, Wenzel HHB, et al
    The prognostic value of the number of positive lymph nodes and the lymph node ratio in early-stage cervical cancer.
    Acta Obstet Gynecol Scand. 2022 Feb 26. doi: 10.1111/aogs.14316.
    PubMed     Abstract available
    
    
    January 2022
26. PARTANEN VM, Heinavaara S, Anttila A, Hakkarainen J, et al
    Setting the record straight-Correcting uterine cancer incidence and mortality in the Nordic countries by reallocation of unspecified cases.
    Acta Obstet Gynecol Scand. 2022 Jan 18. doi: 10.1111/aogs.14314.
    PubMed     Abstract available
    
    
    April 2021
27. GUSTAFSON LW, Petersen LK, Bor P, Andersen B, et al
    Cervical cancer prevention among older women - challenges in screening, diagnostic workup, and treatment.
    Acta Obstet Gynecol Scand. 2021 Apr 18. doi: 10.1111/aogs.14162.
    PubMed     Abstract available
    
    
    
28. KASUGA Y, Ikenoue S, Tanaka Y, Tamagawa M, et al
    Expectant management for early pregnancy miscarriage after radical trachelectomy: a single-hospital-based study.
    Acta Obstet Gynecol Scand. 2021 Apr 2. doi: 10.1111/aogs.14158.
    PubMed     Abstract available
    
    
    
29. MREMI A, Linde DS, Mchome B, Mlay J, et al
    Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: A cross-sectional study nested in a cohort in rural Tanzania.
    Acta Obstet Gynecol Scand. 2021;100:802-810.
    PubMed     Abstract available
    
    
    
30. SWAI P, Kjaer SK, Mchome B, Manongi R, et al
    The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study.
    Acta Obstet Gynecol Scand. 2021;100:775-785.
    PubMed     Abstract available
    
    
    
31. KATANGA J, Kjaer SK, Manongi R, Pembe AB, et al
    Agreement between careHPV and hybrid capture 2 in detecting high-risk HPV in women in Tanzania.
    Acta Obstet Gynecol Scand. 2021;100:786-793.
    PubMed     Abstract available
    
    
    March 2021
32. HAMMER A, Gravitt P
    Clinical implications of transitioning from cytology to human papillomavirus-based cervical cancer screening.
    Acta Obstet Gynecol Scand. 2021;100:371-372.
    PubMed    
    
    
    February 2021
33. THOMSEN LT, Kjaer SK, Munk C, Ornskov D, et al
    Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
    Acta Obstet Gynecol Scand. 2021 Feb 10. doi: 10.1111/aogs.14121.
    PubMed     Abstract available
    
    
    
34. TEGUETE I, Tounkara FK, Diawara B, Traore S, et al
    A population-based combination strategy to improve the cervical cancer screening coverage rate in Bamako, Mali.
    Acta Obstet Gynecol Scand. 2021 Feb 9. doi: 10.1111/aogs.14119.
    PubMed     Abstract available
    
    
    January 2021
35. VAN KOL KG, Ebisch RM, Piek JM, Zusterzeel PL, et al
    Salvage surgery for patients with residual disease after chemoradiation therapy for locally advanced cervical cancer: a systematic review on indication, complications and survival.
    Acta Obstet Gynecol Scand. 2021 Jan 20. doi: 10.1111/aogs.14093.
    PubMed     Abstract available
    
    
    October 2020
36. VEIJALAINEN O, Kares S, Kotaniemi-Talonen L, Kujala P, et al
    Primary HPV screening for cervical cancer: results after two screening rounds in a regional screening program in Finland.
    Acta Obstet Gynecol Scand. 2020 Oct 9. doi: 10.1111/aogs.14021.
    PubMed     Abstract available
    
    
    
37. SCHROLL JB
    Human papilloma virus vaccination and its real-life efficacy.
    Acta Obstet Gynecol Scand. 2020;99:1267-1268.
    PubMed    
    
    
    
38. THAMSBORG LH, Napolitano G, Larsen LG, Lynge E, et al
    High-grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study.
    Acta Obstet Gynecol Scand. 2020;99:1290-1296.
    PubMed     Abstract available
    
    
    January 2020
39. WENZEL HHHB, Kruitwagen RRFPM, Nijman HHW, Bekkers RRLM, et al
    Short-term surgical complications after radical hysterectomy - a nationwide cohort study.
    Acta Obstet Gynecol Scand. 2020 Jan 18. doi: 10.1111/aogs.13812.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.